αCT1 peptide sensitizes glioma cells to temozolomide in a glioblastoma organoid platform-Reference-Cited by-同舟云学术

αCT1 peptide sensitizes glioma cells to temozolomide in a glioblastoma organoid platform

Published:2023-01-03 Issue:4 Volume:120 Page:1108-1119
ISSN:0006-3592
Container-title:Biotechnology and Bioengineering
language:en
Short-container-title:Biotech & Bioengineering

Author:

Che Jingru¹,DePalma Thomas J.¹²,Sivakumar Hemamylammal¹,Mezache Louisa S.¹³,Tallman Miranda M.⁴⁵,Venere Monica²⁵,Swindle‐Reilly Katelyn¹⁶⁷,Veeraraghavan Rengasayee¹³,Skardal Aleksander¹²⁸^ORCID

Affiliation:

1. Department of Biomedical Engineering The Ohio State University Columbus Ohio USA

2. The Ohio State University and Arthur G. James Comprehensive Cancer Center The Ohio State University Columbus Ohio USA

3. Biomedical Sciences Graduate Program The Ohio State University Wexner Medical Center Columbus Ohio USA

4. Dorothy M. Davis Hearth and Lung Research Institute The Ohio State University Columbus Ohio USA

5. Department of Radiation Oncology, James Cancer Hospital and Comprehensive Cancer Center The Ohio State University College of Medicine Columbus Ohio USA

6. Department of Chemical and Biomolecular Engineering The Ohio State University Columbus Ohio USA

7. Department of Ophthalmology and Visual Science The Ohio State University Columbus Ohio USA

8. Center for Cancer Engineering The Ohio State University Columbus Ohio USA

Funder

Pelotonia

National Institutes of Health

American Cancer Society

College of Engineering, Ohio State University

Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute

Publisher

Wiley

Subject